EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines

John S Tregoning, David C Stirling, Ziyin Wang, Katie E Flight, Jonathan C Brown, Anna K Blakney, Paul F McKay, Robert F Cunliffe, Valarmathy Murugaiah, Christopher B Fox, Mitchell Beattie, Ying K Tam und 2 weitere

Molecular Therapy - Nucleic Acids · 2023-03 · 31 · 29-42

DOI: 10.1016/j.omtn.2022.11.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy - Nucleic Acids, 2023-03. Verfasst von John S Tregoning und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Imperial College London, St. Mary's Campus, London, UK. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coalition for Epidemic Preparedness Innovations, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To be effective, RNA vaccines require both in situ translation and the induction of an immune response to recruit cells to the site of immunization. These factors can pull in opposite directions with the inflammation reducing expression of the vaccine antigen. We investigated how formulation affects the acute systemic cytokine response to a self-amplifying RNA (saRNA) vaccine. We compared a cationic polymer (pABOL), a lipid emulsion (nanostructured lipid carrier, NLC), and three lipid nanoparticles (LNP). After immunization, we measured serum cytokines and compared the response to induced antibodies against influenza virus. Formulations that induced a greater cytokine response induced a greater antibody response, with a significant correlation between IP-10, MCP-1, KC, and antigen-specific antibody titers. We then investigated how innate immune sensing and signaling impacted the adaptive immune response to vaccination with LNP-formulated saRNA. Mice that lacked MAVS and are unable to signal through RIG-I-like receptors had an altered cytokine response to saRNA vaccination and had significantly greater antibody responses than wild-type mice. This indicates that the inflammation induced by formulated saRNA vaccines is not solely deleterious in the induction of antibody responses and that targeting specific aspects of RNA vaccine sensing might improve the quality of the response.

Schlagwörter

Stichwörter der Autor:innen

MT: Oligonucleotides: Therapies and Applicationsformulationinflammationinfluenzapandemicsensingvaccine

Autor:innen und Institutionen

  • Department of Infectious Disease, Imperial College London, St. Mary's Campus, London, UK.
  • IDRI, Seattle, WA, USA.
  • Department of Global Health, University of Washington, Seattle, WA, USA.
  • Acuitas Therapeutics, 6190 Agronomy Road, Ste 405, Vancouver, BC, Canada.
  • National Heart and Lung Institute, Imperial College London, St. Mary's Campus, London, UK.

Förderung

  • Coalition for Epidemic Preparedness Innovations
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Tregoning, J. S., Stirling, D. C., Wang, Z., Flight, K. E., Brown, J. C., Blakney, A. K., McKay, P. F., Cunliffe, R. F., Murugaiah, V., Fox, C. B., Beattie, M., Tam, Y. K., Johansson, C., & Shattock, R. J. (2023). Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines. Molecular Therapy - Nucleic Acids, 31, 29-42. https://doi.org/10.1016/j.omtn.2022.11.024

Vancouver

Tregoning JS, Stirling DC, Wang Z, Flight KE, Brown JC, Blakney AK, et al. Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines. Molecular Therapy - Nucleic Acids. 2023;31:29-42. doi:10.1016/j.omtn.2022.11.024

BibTeX
@article{Tregoning2023,
  author = {Tregoning, John S and Stirling, David C and Wang, Ziyin and Flight, Katie E and Brown, Jonathan C and Blakney, Anna K and McKay, Paul F and Cunliffe, Robert F and Murugaiah, Valarmathy and Fox, Christopher B and Beattie, Mitchell and Tam, Ying K and Johansson, Cecilia and Shattock, Robin J},
  title = {Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines},
  journal = {Molecular Therapy - Nucleic Acids},
  year = {2023},
  volume = {31},
  pages = {29--42},
  doi = {10.1016/j.omtn.2022.11.024}
}
Kostenlos starten →